Philip Ashton-Rickardt
Hoofd Techniek/Wetenschap/O&O bij SIGILON THERAPEUTICS, INC.
Vermogen: - $ op 31-07-2023
Actieve functies van Philip Ashton-Rickardt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 14-06-2021 | - |
Loopbaan van Philip Ashton-Rickardt
Eerdere bekende functies van Philip Ashton-Rickardt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01-01-2019 | 01-06-2021 |
Smith Therapeutics, Inc.
 Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Smith Therapeutics, Inc. operates as a biopharmaceutical firm which treats neurodegenerative disease. The company was founded by Philip Ashton-Rickardt in 2017 and is headquartered in Chestnut, MA. | Directeur/Bestuurslid | 01-01-2017 | 31-10-2019 |
| Algemeen Directeur | 01-01-2017 | 31-10-2019 | |
| Oprichter | 01-01-2017 | 31-10-2019 | |
| President | 01-01-2017 | 31-10-2019 | |
| Bedrijfssecretaris | 01-01-2017 | 31-10-2019 | |
| The University of Chicago | Corporate Officer/Principal | 01-06-1995 | 01-06-2006 |
| Imperial College London | Corporate Officer/Principal | - | - |
Opleiding van Philip Ashton-Rickardt
| King's College London | Undergraduate Degree |
| The University of Edinburgh | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 4 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Smith Therapeutics, Inc.
Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Smith Therapeutics, Inc. operates as a biopharmaceutical firm which treats neurodegenerative disease. The company was founded by Philip Ashton-Rickardt in 2017 and is headquartered in Chestnut, MA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
